• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

ADAMTS8 促进肺动脉高压和右心衰竭的发展:一个可能的新治疗靶点。

ADAMTS8 Promotes the Development of Pulmonary Arterial Hypertension and Right Ventricular Failure: A Possible Novel Therapeutic Target.

机构信息

From the Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine, Sendai, Japan (J.O., K.S., N.K., T.S., R.K., M.N., T.O., M.E.A.-M., M.A.H.S., N.Y.; S.S., S.M., H.S.).

Department of Thoracic Surgery, Fujita Health University School of Medicine, Toyoake, Japan (Y.H.).

出版信息

Circ Res. 2019 Oct 25;125(10):884-906. doi: 10.1161/CIRCRESAHA.119.315398. Epub 2019 Sep 26.

DOI:10.1161/CIRCRESAHA.119.315398
PMID:31556812
Abstract

RATIONALE

Pulmonary arterial hypertension (PAH) is characterized by pulmonary vascular remodeling with aberrant pulmonary artery smooth muscle cells (PASMCs) proliferation, endothelial dysfunction, and extracellular matrix remodeling.

OBJECTIVE

Right ventricular (RV) failure is an important prognostic factor in PAH. Thus, we need to elucidate a novel therapeutic target in both PAH and RV failure.

METHODS AND RESULTS

We performed microarray analysis in PASMCs from patients with PAH (PAH-PASMCs) and controls. We found a ADAMTS8 (disintegrin and metalloproteinase with thrombospondin motifs 8), a secreted protein specifically expressed in the lung and the heart, was upregulated in PAH-PASMCs and the lung in hypoxia-induced pulmonary hypertension (PH) in mice. To elucidate the role of ADAMTS8 in PH, we used vascular smooth muscle cell-specific ADAMTS8-knockout mice (ADAMTS). Hypoxia-induced PH was attenuated in ADAMTS mice compared with controls. ADAMTS8 overexpression increased PASMC proliferation with downregulation of AMPK (AMP-activated protein kinase). In contrast, deletion of ADAMTS8 reduced PASMC proliferation with AMPK upregulation. Moreover, deletion of ADAMTS8 reduced mitochondrial fragmentation under hypoxia in vivo and in vitro. Indeed, PASMCs harvested from ADAMTS mice demonstrated that phosphorylated DRP-1 (dynamin-related protein 1) at Ser637 was significantly upregulated with higher expression of profusion genes (Mfn1 and Mfn2) and improved mitochondrial function. Moreover, recombinant ADAMTS8 induced endothelial dysfunction and matrix metalloproteinase activation in an autocrine/paracrine manner. Next, to elucidate the role of ADAMTS8 in RV function, we developed a cardiomyocyte-specific ADAMTS8 knockout mice (ADAMTS8). ADAMTS8 mice showed ameliorated RV failure in response to chronic hypoxia. In addition, ADAMTS8 mice showed enhanced angiogenesis and reduced RV ischemia and fibrosis. Finally, high-throughput screening revealed that mebendazole, which is used for treatment of parasite infections, reduced ADAMTS8 expression and cell proliferation in PAH-PASMCs and ameliorated PH and RV failure in PH rodent models.

CONCLUSIONS

These results indicate that ADAMTS8 is a novel therapeutic target in PAH.

摘要

背景

肺动脉高压(PAH)的特征是肺血管重构,伴有肺动脉平滑肌细胞(PASMC)异常增殖、内皮功能障碍和细胞外基质重构。

目的

右心室(RV)衰竭是 PAH 的一个重要预后因素。因此,我们需要在 PAH 和 RV 衰竭中阐明一个新的治疗靶点。

方法和结果

我们对 PAH 患者(PAH-PASMCs)和对照组的 PASMC 进行了微阵列分析。我们发现,一种在肺和心脏中特异性表达的分泌蛋白 ADAMTS8(解整合素和金属蛋白酶与凝血酶样 8)在 PAH-PASMCs 和缺氧诱导的肺动脉高压(PH)小鼠的肺中上调。为了阐明 ADAMTS8 在 PH 中的作用,我们使用血管平滑肌细胞特异性 ADAMTS8 敲除小鼠(ADAMTS)。与对照组相比,缺氧诱导的 PH 在 ADAMTS 小鼠中减弱。ADAMTS8 过表达增加 PASMC 增殖,同时下调 AMPK(AMP 激活的蛋白激酶)。相反,ADAMTS8 的缺失减少了低氧条件下 PASMC 的增殖,同时上调了 AMPK。此外,ADAMTS8 的缺失减少了体内和体外低氧条件下的线粒体片段化。事实上,从 ADAMTS 小鼠中分离出的 PASMC 显示,磷酸化 DRP-1(dynamin-related protein 1)在 Ser637 处显著上调,融合基因(Mfn1 和 Mfn2)表达增加,线粒体功能改善。此外,重组 ADAMTS8 以自分泌/旁分泌方式诱导内皮功能障碍和基质金属蛋白酶激活。接下来,为了阐明 ADAMTS8 在 RV 功能中的作用,我们开发了一种心肌细胞特异性 ADAMTS8 敲除小鼠(ADAMTS8)。ADAMTS8 小鼠在慢性缺氧时表现出 RV 衰竭的改善。此外,ADAMTS8 小鼠表现出增强的血管生成和减少的 RV 缺血和纤维化。最后,高通量筛选显示,用于治疗寄生虫感染的甲苯咪唑可降低 PAH-PASMCs 中的 ADAMTS8 表达和细胞增殖,并改善 PH 啮齿动物模型中的 PH 和 RV 衰竭。

结论

这些结果表明 ADAMTS8 是 PAH 的一个新的治疗靶点。

相似文献

1
ADAMTS8 Promotes the Development of Pulmonary Arterial Hypertension and Right Ventricular Failure: A Possible Novel Therapeutic Target.ADAMTS8 促进肺动脉高压和右心衰竭的发展:一个可能的新治疗靶点。
Circ Res. 2019 Oct 25;125(10):884-906. doi: 10.1161/CIRCRESAHA.119.315398. Epub 2019 Sep 26.
2
Identification of Celastrol as a Novel Therapeutic Agent for Pulmonary Arterial Hypertension and Right Ventricular Failure Through Suppression of Bsg (Basigin)/CyPA (Cyclophilin A).通过抑制 Bsg(Basigin)/CyPA(Cyclophilin A),鉴定鬼臼毒素作为肺动脉高压和右心衰竭的新型治疗药物。
Arterioscler Thromb Vasc Biol. 2021 Mar;41(3):1205-1217. doi: 10.1161/ATVBAHA.120.315731. Epub 2021 Jan 21.
3
Selenoprotein P Promotes the Development of Pulmonary Arterial Hypertension: Possible Novel Therapeutic Target.硒蛋白 P 促进肺动脉高压的发生:可能的新型治疗靶点。
Circulation. 2018 Aug 7;138(6):600-623. doi: 10.1161/CIRCULATIONAHA.117.033113.
4
Identification of Long Noncoding RNA H19 as a New Biomarker and Therapeutic Target in Right Ventricular Failure in Pulmonary Arterial Hypertension.鉴定长链非编码 RNA H19 作为肺动脉高压右心衰竭的新生物标志物和治疗靶点。
Circulation. 2020 Oct 13;142(15):1464-1484. doi: 10.1161/CIRCULATIONAHA.120.047626. Epub 2020 Jul 23.
5
Ultrastructural Changes of the Right Ventricular Myocytes in Pulmonary Arterial Hypertension.肺动脉高压右心室心肌细胞的超微结构变化。
J Am Heart Assoc. 2019 Mar 5;8(5):e011227. doi: 10.1161/JAHA.118.011227.
6
Identification of Celastramycin as a Novel Therapeutic Agent for Pulmonary Arterial Hypertension.鉴定鬼臼霉素为肺动脉高压的新型治疗药物。
Circ Res. 2019 Jul 19;125(3):309-327. doi: 10.1161/CIRCRESAHA.119.315229. Epub 2019 Jun 14.
7
Transcriptomic Analysis of Right Ventricular Remodeling in Two Rat Models of Pulmonary Hypertension: Identification and Validation of Epithelial-to-Mesenchymal Transition in Human Right Ventricular Failure.转录组分析两种肺动脉高压大鼠模型右心室重构:人类右心衰竭中上皮-间充质转化的鉴定和验证。
Circ Heart Fail. 2021 Feb;14(2):e007058. doi: 10.1161/CIRCHEARTFAILURE.120.007058. Epub 2021 Feb 5.
8
Canagliflozin inhibits PASMCs proliferation via regulating SGLT1/AMPK signaling and attenuates artery remodeling in MCT-induced pulmonary arterial hypertension.坎格列净通过调节 SGLT1/AMPK 信号通路抑制 PASMCs 增殖,减轻 MCT 诱导的肺动脉高压大鼠的血管重构。
Biomed Pharmacother. 2024 May;174:116505. doi: 10.1016/j.biopha.2024.116505. Epub 2024 Apr 4.
9
Sulforaphane prevents right ventricular injury and reduces pulmonary vascular remodeling in pulmonary arterial hypertension.萝卜硫素可预防肺动脉高压右心室损伤并减少肺血管重构。
Am J Physiol Heart Circ Physiol. 2020 Apr 1;318(4):H853-H866. doi: 10.1152/ajpheart.00321.2019. Epub 2020 Feb 28.
10
GRK2-YAP signaling is implicated in pulmonary arterial hypertension development.GRK2-YAP 信号通路与肺动脉高压的发生发展有关。
Chin Med J (Engl). 2024 Apr 5;137(7):846-858. doi: 10.1097/CM9.0000000000002946. Epub 2024 Jan 19.

引用本文的文献

1
Genetic Pathogenesis of Abdominal Aortic Aneurysm and the Role of PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9).腹主动脉瘤的遗传发病机制及前蛋白转化酶枯草溶菌素/kexin 9型(PCSK9)的作用
Vasc Specialist Int. 2025 Sep 11;41:26. doi: 10.5758/vsi.250043.
2
SETD2 drives METTL14-mediated mA to suppress Piezo1 Attenuation and activate TGM2 to promote pulmonary hypertension.SET结构域蛋白2驱动METTL14介导的N6-甲基腺苷修饰以抑制Piezo1衰减并激活转谷氨酰胺酶2以促进肺动脉高压。
Cell Mol Life Sci. 2025 Aug 8;82(1):302. doi: 10.1007/s00018-025-05809-3.
3
Chlorogenic acid attenuates cardiac hypertrophy and fibrosis by downregulating galectin 3.
绿原酸通过下调半乳糖凝集素3减轻心脏肥大和纤维化。
Sci Rep. 2025 Jul 24;15(1):26925. doi: 10.1038/s41598-025-12222-0.
4
Maternal Electronic Cigarette Exposure Induces Dysregulation of Autophagy via Oxidative Stress/DNA Methylation in Pulmonary Hypertension Offspring.母体电子烟暴露通过氧化应激/DNA甲基化诱导肺动脉高压后代自噬失调。
Curr Med Sci. 2025 Jun 24. doi: 10.1007/s11596-025-00074-8.
5
Characterization of ADAMTS9 proteoglycanase activity: Comparison with ADAMTS1, ADAMTS4, and ADAMTS5.ADAMTS9蛋白聚糖酶活性的表征:与ADAMTS1、ADAMTS4和ADAMTS5的比较。
J Biol Chem. 2025 May 29;301(7):110301. doi: 10.1016/j.jbc.2025.110301.
6
Unraveling AURKB as a potential therapeutic target in pulmonary hypertension using integrated transcriptomic analysis and pre-clinical studies.利用综合转录组分析和临床前研究揭示AURKB作为肺动脉高压潜在治疗靶点的作用
Cell Rep Med. 2025 Feb 18;6(2):101964. doi: 10.1016/j.xcrm.2025.101964. Epub 2025 Feb 10.
7
The role and mechanism of AMPK in pulmonary hypertension.AMPK 在肺动脉高压中的作用及其机制。
Ther Adv Respir Dis. 2024 Jan-Dec;18:17534666241271990. doi: 10.1177/17534666241271990.
8
Exosomes enriched by miR-429-3p derived from ITGB1 modified Telocytes alleviates hypoxia-induced pulmonary arterial hypertension through regulating Rac1 expression.由 ITGB1 修饰的 Telocytes 来源的富含 miR-429-3p 的外泌体通过调节 Rac1 表达缓解低氧诱导的肺动脉高压。
Cell Biol Toxicol. 2024 May 20;40(1):32. doi: 10.1007/s10565-024-09879-0.
9
Combined genetic-pharmacologic inactivation of tightly linked ADAMTS proteases in temporally specific windows uncovers distinct roles for versican proteolysis and glypican-6 in cardiac development.在特定时间窗口内联合遗传药理学失活紧密连锁的 ADAMTS 蛋白酶,揭示了 versican 蛋白水解和 glypican-6 在心脏发育中的不同作用。
Matrix Biol. 2024 Aug;131:1-16. doi: 10.1016/j.matbio.2024.05.003. Epub 2024 May 13.
10
The genetic architecture of the human hypothalamus and its involvement in neuropsychiatric behaviours and disorders.人类下丘脑的遗传结构及其在神经精神行为和障碍中的作用。
Nat Hum Behav. 2024 Apr;8(4):779-793. doi: 10.1038/s41562-023-01792-6. Epub 2024 Jan 5.